It's been an incredible year!

It’s been an incredible year for Cancer Grand Challenges. From announcing 4 new funded teams, to our first Future Leaders Conference in Barcelona and opening the round 4 challenge consultation, with 8 workshops in 5 countries.

Thank you to all of you who have supported our global initiative – the research community, patient advocates and our generous partners. To celebrate this year, we're sharing some highlights from the past 12 months. You can discover more below.

We look forward to continuing our journey with you in 2023, as we prepare to announce our fourth round of funding and a set of new challenges. Cancer Grand Challenges wishes you, your family, friends and colleagues a happy, healthy festive season!

Best wishes,

David Scott, Director, Cancer Grand Challenges, Cancer Research UK and Dinah Singer, Deputy Director, National Cancer Institute

Team science news

Over this past year, we’ve seen plenty of exciting developments and innovations coming out of our funded teams. Lorenzo de la Rica, Research Portfolio Manager at Cancer Grand Challenges, shares some 2022 highlights emerging from our round 1 teams.

Learn more

4 new teams awarded $100m

At our 2022 Summit, we announced 4 new teams receiving $100m worth of funding to take on cancer’s toughest challenges. These were the first teams to be funded through our partnership with Cancer Research UK and the National Cancer Institute in the US.

Round 4 consultation

In October, we launched a global campaign to identify a new set of challenges. Over 300 ideas were submitted by researchers, clinicians, patient advocates and supporters. The final set of challenges will be announced in March 2023 at our annual Summit. Our Head of Research, Sheona Scales, talks about the importance of the consultation process.

Read the Q&A

Putting patients at the heart of our work

It’s imperative that the work we do translates into tangible impact for people affected by cancer across the globe. We work with patient advocates across all our funded teams and are guided by our Advocacy Panel.

Sara Wakeling, CEO and co-founder of Alice's Arc and patient advocate for the Cancer Grand Challenges NexTGen team, describes the team’s work as having "hope written all over it".

Read Sara's experience

Key dates for 2023

March 2023: New challenges announced at the Summit and expressions of interest open
June 2023: Deadline for expressions of interest
August 2023: Shortlisted teams announced and seed funding issued
March 2024: New funded teams announced

Cancer Grand Challenges

2 Redman Place

London, London E20 1JQ

United Kingdom

Add us to your address book

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.